SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062993-21-003164
Filing Date
2021-03-31
Accepted
2021-03-30 18:24:35
Documents
79
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A form20fa.htm 20-F/A 987558
2 EXHIBIT 12.1 exhibit12-1.htm EX-12.1 6627
3 EXHIBIT 12.2 exhibit12-2.htm EX-12.2 5854
4 EXHIBIT 13.1 exhibit13-1.htm EX-13.1 3685
5 EXHIBIT 13.2 exhibit13-2.htm EX-13.2 5133
  Complete submission text file 0001062993-21-003164.txt   6981955

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY INSTANCE DOCUMENT repcf-20191231.xml EX-101.INS 1689969
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repcf-20191231.xsd EX-101.SCH 105061
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repcf-20191231_cal.xml EX-101.CAL 24640
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repcf-20191231_def.xml EX-101.DEF 220868
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT repcf-20191231_lab.xml EX-101.LAB 747076
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repcf-20191231_pre.xml EX-101.PRE 365296
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-50112 | Film No.: 21788846
SIC: 2836 Biological Products, (No Diagnostic Substances)